CDC & FDA Ignored Crucial Military Investigation

A non-profit organization, The Informed Consent Action Network (ICAN), has unveiled documents through the Freedom of Information Act (FOIA). These papers highlight potential oversight by both the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) and with a U.S. military investigation. This investigation carried out in January 2021, reportedly showed evidence of vaccine inefficacies.
These FOIA-acquired documents by ICAN indicate that the CDC and FDA might have overlooked vital data concerning vaccine efficacy. ICAN’s analysis suggests that a U.S. military probe from early 2021 unveiled potential vaccine shortcomings. Yet, there seems to be an alleged lack of action or recognition from the CDC and FDA.

Using FOIA channels, the organization’s legal representatives have come across a presentation from September 2021. This presentation was shared with senior FDA and NIH officials, such as Anthony Fauci, Francis Collins, Peter Marks, and Janet Woodcock. The content highlighted startling data about reduced immunity and increased cases of breakthrough infections among vaccinated individuals as of July 2021.

Humetrix Cloud Services, acclaimed for its proficiency in healthcare tech solutions, has been granted a contract by the U.S. military. Their responsibility is to extensively examine vaccine data, aiming to provide the military with a clearer understanding of vaccine distribution and efficacy.

Recent studies have raised concerns about increasing COVID-19 cases among older adults. The research shows that vaccinated individuals, surprisingly, represent a significant fraction of total cases within this demographic.

New data reveal that the rise of breakthrough cases might have roots dating back to January 2021. Remarkably, the data from the final week of July indicates that 73 percent of COVID-19 cases and 63 percent of hospitalizations in the age group of 65 and above were among fully vaccinated people. This presents a troubling picture of decreasing immunity, where infection rates seem to increase significantly after 5-6 months post-vaccination compared to 3-4 months post-vaccination rates.

Despite these alarming trends, as of December 2021, the CDC continued to assert that vaccines provide protection levels comparable to what was observed during clinical trials. They claimed that fully vaccinated individuals reduced the risk of severe illness by 90 percent.

Interestingly, communication lapses were evident when Peter Marks, Director of CBER, mentioned to Janet Woodcock, Acting Commissioner of FDA, the desirability of CDC sharing such pivotal data.

ICAN’s legal team remains steadfast in its mission to shed light on what the government knew about vaccine efficacy and when it became aware of it.